NUTRA
PHARMA CORP.
|
(Exact
name of registrant as specified in its
charter)
|
California
|
000-32141
|
91-2021600
|
(State
or jurisdiction of
|
(Commission
|
(I.R.S.
Employer
|
incorporation
or organization)
|
File
Number)
|
Identification
No.)
|
1537
NW 65th Avenue
|
Plantation
Florida 33313
|
(Address
of principal executive offices) (Zip
Code)
|
Registrant's
telephone number: 954-509-0911
|
●
|
We
are not and were not a blank check company at the time of the offer or
sale;
|
●
|
The
investors had business experience and were accredited investors as defined
by Rule 501 of Regulation D of the
Act;
|
●
|
All
offers and sales of the investment were made privately and no party
engaged in any general solicitation or advertising of the proposed
investment;
|
●
|
Each
investor had a preexisting social, personal or business relationship with
us and members of our management;
|
●
|
The
investors were provided with all information sufficient to allow them to
make an informed investment
decision;
|
●
|
The
investors had the opportunity to inspect our books and records and to
verify statements made to them;
|
●
|
The
securities representing the investment were issued with a restrictive
legend indicating the securities represented by the certificate have not
been registered; and
|
●
|
No
party received any transaction-based compensation such as
commissions.
|